Capitalize on the ADME-Toxicology Testing Shift: Benchmark Charles River, Thermo Fisher, Eurofins, WuXi AppTec and Evotec to Accelerate R&D ROI and Outpace Disruption
Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "ADME-Toxicology Testing - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for ADME-Toxicology Testing was valued at US$10 Billion in 2024 and is projected to reach US$18.8 Billion by 2030, growing at a CAGR of 11.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the ADME-Toxicology Testing market.
Global ADME-Toxicology Testing Market - Key Trends and Drivers Summarized
ADME-Toxicology Testing is a critical process in pharmacology, referring to the assessment of Absorption, Distribution, Metabolism, and Excretion (ADME) properties of potential pharmaceutical compounds alongside their toxicological profiles. This type of testing is fundamental in drug development, providing essential data that predicts how substances behave in the body, which can impact drug safety and efficacy. The toxicological tests evaluate potential adverse effects caused by drug candidates, helping to identify any toxic risk associated with drug intake. ADME-Toxicology testing is not only a regulatory requirement but also a crucial step to ensure that only safe and efficacious drugs reach clinical trials and eventually the market, thereby safeguarding public health.
The demand for ADME-Toxicology testing has surged with the expansion of the pharmaceutical industry and the introduction of more complex biologic drugs which require intricate safety assessments. Modern testing methods now often employ sophisticated technologies such as high-throughput screening and molecular modeling to predict ADME-Tox profiles efficiently and accurately. Additionally, the integration of in vitro and in silico models has enhanced the predictive capabilities of these tests, reducing the reliance on animal testing and aligning with the global push towards more ethical research practices. These advancements not only expedite the drug development process but also improve its cost-effectiveness, enabling researchers to screen out potential failures earlier in the development cycle. The increasing complexity of new therapeutic agents, including targeted therapies and personalized medicine, further necessitates the detailed and precise analysis provided by advanced ADME-Tox studies.
The growth in the ADME-Toxicology testing market is driven by several factors. Technological advancements that offer more rapid, accurate, and cost-effective testing methods are a primary driver. As pharmaceutical companies continue to seek ways to reduce the time and cost associated with drug development, these advanced technologies become increasingly attractive. Additionally, regulatory requirements have become more stringent worldwide, demanding more comprehensive toxicity and efficacy data before a drug can be approved. This regulatory landscape ensures continual demand for ADME-Tox testing services. Moreover, the growing focus on personalized medicine and the development of drugs with narrower therapeutic indices call for more detailed and customized toxicity testing, further propelling the market. Finally, the ethical push towards reducing animal testing in drug development encourages the adoption of alternative in vitro and in silico methods, aligning market expansion with broader ethical standards. These factors collectively ensure sustained growth in the ADME-Toxicology testing market, highlighting its critical role in advancing safe and effective pharmaceuticals.
Report Scope
The report analyzes the ADME-Toxicology Testing market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.
Key Insights:
Why You Should Buy This Report:
Key Questions Answered:
Report Features:
Some of the 79 companies featured in this ADME-Toxicology Testing market report include:
This edition integrates the latest global trade and economic shifts into comprehensive market analysis. Key updates include:
Key Attributes:
For more information about this report visit https://www.researchandmarkets.com/r/3tdqe2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.